OREX Share Price

Open 1.89 Change Price %
High 1.95 1 Day 0.04 2.11
Low 1.84 1 Week -0.02 -1.02
Close 1.94 1 Month -0.25 -11.42
Volume 95759 1 Year 0.04 2.11
52 Week High 4.75
52 Week Low 0.35
OREX Important Levels
Resistance 2 2.04
Resistance 1 2.00
Pivot 1.91
Support 1 1.88
Support 2 1.84
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
WRES 0.09 0.00%
SIRI 4.41 1.85%
QQQ 116.87 0.23%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ECTE 0.14 40.00%
BNSO 3.57 31.25%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
FRAN 20.01 28.76%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
CRDS 5.45 25.87%
OTT 2.39 25.13%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
IMRS 0.02 -33.33%
More..

Orexigen Therapeutics, Inc. (NASDAQ: OREX)

OREX Technical Analysis 2
As on 6th Dec 2016 OREX Share Price closed @ 1.94 and we RECOMMEND Buy for LONG-TERM with Stoploss of 1.90 & Strong Sell for SHORT-TERM with Stoploss of 2.68 we also expect STOCK to react on Following IMPORTANT LEVELS.
OREX Target for December
1st Target up-side 2.34
2nd Target up-side 2.61
3rd Target up-side 2.88
1st Target down-side 1.58
2nd Target down-side 1.31
3rd Target down-side 1.04
OREX Other Details
Segment EQ
Market Capital 344798624.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.orexigen.com
OREX Address
OREX
3344 North Torrey Pines Court
Suite 200
La Jolla, CA 92037
United States
Phone: 858-875-8600
Fax: 858-875-8650
Interactive Technical Analysis Chart Orexigen Therapeutics, Inc. ( OREX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Orexigen Therapeutics, Inc.
OREX Business Profile
Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.